title: [Therapy of psoriasis vulgaris with efalizumab].
authors.affiliation: Universitäts-Hauklinik Kiel. UMrowietz@dermatology.uni-kiel.de
authors.forename: Ulrich
authors.initials: U
authors.lastname: Mrowietz
authors.forename: Joachim
authors.initials: J
authors.lastname: Barth
authors.forename: Wolf-Henning
authors.initials: WH
authors.lastname: Boehncke
authors.forename: Kristian
authors.initials: K
authors.lastname: Reich
authors.forename: Thomas
authors.initials: T
authors.lastname: Rosenbach
authors.forename: Volker
authors.initials: V
authors.lastname: Streit
authors.forename: Gottfried
authors.initials: G
authors.lastname: Wozel
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects; D061067:Antibodies, Monoclonal, Humanized; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D008134:Long-Term Care; D011565:Psoriasis / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C472181:efalizumab